Table II. In vitro potency of ustekinumab and guselkumab on cytokine production.
| IC50 (nM) | |||
|---|---|---|---|
| Cytokine | GUS | UST | Increased Potency of GUSa |
| IL-17A | 0.10 | 0.38 | 3.8 |
| IL-17F | 0.11 | 0.49 | 4.5 |
| IL-22 | 0.09 | 0.40 | 4.4 |
UST IC50:GUS IC50.
GUS, guselkumab; UST, ustekinumab.
| IC50 (nM) | |||
|---|---|---|---|
| Cytokine | GUS | UST | Increased Potency of GUSa |
| IL-17A | 0.10 | 0.38 | 3.8 |
| IL-17F | 0.11 | 0.49 | 4.5 |
| IL-22 | 0.09 | 0.40 | 4.4 |
UST IC50:GUS IC50.
GUS, guselkumab; UST, ustekinumab.